Merck Korea will launch its unique growth hormone injection device, easypod, from next month for the once-daily administration of Saizen (somatropin), the company's recombinant growth hormone deficiency therapy.
A 2007 Gold Medal recipient of the Medical Design Excellence Awards, easypod was designed in conjunction with patients, caregivers and healthcare professionals to answer the need for...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.